AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30242322 — intervention group
Group type: EXPERIMENTAL
Intervention: VABS‐II (Vineland Adaptive Behavior Scales, Second Edition)
Number of subjects: 222
Study 26949875 — intervention group
Group type: EXPERIMENTAL
Intervention: WSM (web-based mindfulness stress management program)
Number of subjects: 161
Study 26949875 — intervention group
Group type: EXPERIMENTAL
Intervention: WSM with group support
Number of subjects: 161
Study 26949875 — intervention group
Group type: EXPERIMENTAL
Intervention: WSM with group and expert clinical support
Number of subjects: 161
Study 26949875 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 161
Study 25005452 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 20 mg orally once daily
Number of subjects: 250
Study 25005452 — intervention group
Group type: COMPARATOR
Intervention: Dose-adjusted oral vitamin K antagonist (VKA)
Number of subjects: 250
Study 22465911 — intervention group
Group type: EXPERIMENTAL
Intervention: Biennial LDCT screening
Number of subjects: 4099
Study 22465911 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual LDCT screening
Number of subjects: 4099
Study 22465911 — intervention group
Group type: COMPARATOR
Intervention: Control group (observation)
Number of subjects: 4099
Study 20423395 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare professional‐led rehabilitation programme
Number of subjects: 58
Study 20423395 — intervention group
Group type: COMPARATOR
Intervention: Self‐managed rehabilitation programme
Number of subjects: 58
Study 18924480 — intervention group
Group type: EXPERIMENTAL
Intervention: Vejnović modification
Number of subjects: 1886
Study 18924480 — intervention group
Group type: COMPARATOR
Intervention: Common operative technique
Number of subjects: 1886
Study 15829577 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg)
Number of subjects: 42
Study 15829577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 15829577 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab + Methotrexate
Number of subjects: 42
Study 15829577 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate monotherapy
Number of subjects: 42
Study 11879260 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (100-mg single dose)
Number of subjects: 17
Study 11879260 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 11686667 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour on-site catheterization facilities
Number of subjects: 15078
Study 11686667 — intervention group
Group type: COMPARATOR
Intervention: Day-only on-site catheterization facilities
Number of subjects: 15078
Study 11686667 — intervention group
Group type: COMPARATOR
Intervention: No on-site catheterization facilities
Number of subjects: 15078
Study 9226059 — intervention group
Group type: EXPERIMENTAL
Intervention: loratadine (10 mg OD)
Number of subjects: 139
Study 7904786 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxatidine acetate (150 mg once daily)
Number of subjects: 11
Study 7904786 — intervention group
Group type: COMPARATOR
Intervention: Ethanol (0.3 g/kg)
Number of subjects: 11
Study 3523713 — intervention group
Group type: EXPERIMENTAL
Intervention: trimethoprim‐sulfamethoxazole (160 mg/800 mg daily)
Number of subjects: 433
Study 3523713 — intervention group
Group type: EXPERIMENTAL
Intervention: trimethoprim (200 mg daily)
Number of subjects: 433
Study 3523713 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 433
Study 3523713 — intervention group
Group type: EXPERIMENTAL
Intervention: bicozamycin (500 mg four times daily)
Number of subjects: 433
Study 3523713 — intervention group
Group type: EXPERIMENTAL
Intervention: norfloxacin (400 mg daily)
Number of subjects: 433
Study 29567630 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril started before chemotherapy (prevention arm)
Number of subjects: 273
Study 29567630 — intervention group
Group type: COMPARATOR
Intervention: Enalapril started only in patients with an increase in troponin during or after chemotherapy (troponin-triggered arm)
Number of subjects: 273
Study 29567630 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (prevention and troponin-triggered)
Number of subjects: 273
Study 29354992 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion at Geshu (BL 17), once a day for 4 sessions (2 weeks each session)
Number of subjects: 70
Study 29354992 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of cilostazol, 50 mg, twice a day for 4 sessions (2 weeks each session)
Number of subjects: 70
Study 25736283 — intervention group
Group type: EXPERIMENTAL
Intervention: Evacetrapib 130 mg/d following a high-fat breakfast
Number of subjects: 40
Study 25736283 — intervention group
Group type: COMPARATOR
Intervention: Evacetrapib 130 mg/d following a 10-hour fast
Number of subjects: 40
Study 25736283 — intervention group
Group type: EXPERIMENTAL
Intervention: Evacetrapib 130 mg/d (both fed and fasted states)
Number of subjects: 40
Study 23444983 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-carbohydrate diet (41:19:40% energy from carbohydrate/protein/fat)
Number of subjects: 30
Study 23444983 — intervention group
Group type: COMPARATOR
Intervention: Standard diet (55:18:27% energy from carbohydrate/protein/fat)
Number of subjects: 30
Study 21178093 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient powder (MNP) containing 2.5 mg iron as NaFeEDTA and 2.5 mg zinc, added to high-phytate maize porridge 5 days/week for 23 weeks
Number of subjects: 200
Study 21178093 — intervention group
Group type: COMPARATOR
Intervention: Unfortified carrier added to high-phytate maize porridge
Number of subjects: 200
Study 19064623 — intervention group
Group type: EXPERIMENTAL
Intervention: RTS,S/AS02D vaccine
Number of subjects: 340
Study 19064623 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis B vaccine
Number of subjects: 340
Study 16552215 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemic management
Number of subjects: 0
Study 16552215 — intervention group
Group type: COMPARATOR
Intervention: Hyperglycemia during cardiac surgery
Number of subjects: 0
Study 14689177 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-educational and therapeutic alliance intervention
Number of subjects: 0
Study 14689177 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 10975476 — intervention group
Group type: EXPERIMENTAL
Intervention: Double filtration plasmapheresis (DF)
Number of subjects: 94
Study 10975476 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoadsorption plasmapheresis (IA)
Number of subjects: 94
Study 10975476 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange (PE)
Number of subjects: 94
Study 10975476 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily schedule of plasmapheresis
Number of subjects: 94
Study 10975476 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal number of PP sessions
Number of subjects: 94
Study 10975476 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors correlating with better clinical response
Number of subjects: 94
Study 9368546 — intervention group
Group type: EXPERIMENTAL
Intervention: Early outpatient treatment for PTSD for 6 months
Number of subjects: 0
Study 9368546 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly people
Number of subjects: 0
Study 9368546 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial factors
Number of subjects: 0
Study 1391980 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 0
Study 1391980 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with tamoxifen and medroxyprogesterone acetate
Number of subjects: 0
Study 29940126 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop insulin delivery
Number of subjects: 136
Study 29940126 — intervention group
Group type: COMPARATOR
Intervention: Conventional subcutaneous insulin therapy
Number of subjects: 136
Study 26690641 — intervention group
Group type: EXPERIMENTAL
Intervention: ESM self‐monitoring intervention
Number of subjects: 102
Study 26690641 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 102
Study 25609011 — intervention group
Group type: EXPERIMENTAL
Intervention: Zovirax 200 mg dispersible tablets co-administered with 400 mg chitosan HCl
Number of subjects: 12
Study 25609011 — intervention group
Group type: EXPERIMENTAL
Intervention: Zovirax 200 mg dispersible tablets co-administered with 1000 mg chitosan HCl
Number of subjects: 12
Study 25609011 — intervention group
Group type: COMPARATOR
Intervention: Zovirax only
Number of subjects: 12
Study 23400856 — intervention group
Group type: EXPERIMENTAL
Intervention: Color characters (e.g., hong2, 'red')
Number of subjects: 0
Study 23400856 — intervention group
Group type: EXPERIMENTAL
Intervention: Homophones of the color characters (S+T+) (e.g., hong2, 'flood')
Number of subjects: 0
Study 23400856 — intervention group
Group type: EXPERIMENTAL
Intervention: Different-tone homophones (S+T-) (e.g., hong1, 'boom')
Number of subjects: 0
Study 23400856 — intervention group
Group type: EXPERIMENTAL
Intervention: Characters that shared the same tone but differed in segments with the color characters (S-T+) (e.g., ping2, 'bottle')
Number of subjects: 0
Study 23400856 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral characters (S-T-) (e.g., qian1, 'leading through')
Number of subjects: 0
Study 21911098 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive individual psychotherapy followed by combined psychodynamic and cognitive‐behavioral group therapy (total of 28 sessions).
Number of subjects: 569
Study 21911098 — intervention group
Group type: COMPARATOR
Intervention: One psychosocial counseling session.
Number of subjects: 569
Study 17764465 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glulisine
Number of subjects: 18
Study 17764465 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro
Number of subjects: 18
Study 17764465 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular human insulin (RHI)
Number of subjects: 18
Study 16642610 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep needling at Ermen (TE 21), Tinggong (SI 19), and Tinghui (GB 2) combined with body acupuncture
Number of subjects: 47
Study 16642610 — intervention group
Group type: COMPARATOR
Intervention: Shallow needling at Ermen (TE 21), Tinggong (SI 19), and Tinghui (GB 2) combined with body acupuncture
Number of subjects: 47
Study 12716487 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuIFN-gamma (100 microg subcutaneously)
Number of subjects: 46
Study 12716487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 11134132 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRP-2 alone
Number of subjects: 9
Study 11134132 — intervention group
Group type: COMPARATOR
Intervention: GHRH alone
Number of subjects: 9
Study 11134132 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox + GHRH
Number of subjects: 9
Study 11134132 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox + GHRP-2
Number of subjects: 9
Study 11134132 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal FFAs
Number of subjects: 9
Study 11134132 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRP-2 administration
Number of subjects: 9
Study 8800308 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iloprost 0.5‐2.0 ng/kg/min for 6 h from 8 to 13 days
Number of subjects: 12
Study 1464049 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical capsaicin pre-treatment
Number of subjects: 12
Study 6397182 — intervention group
Group type: EXPERIMENTAL
Intervention: High humidity atmosphere
Number of subjects: 16
Study 6397182 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 16
Study 31830082 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling
Number of subjects: 20
Study 31830082 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait
Number of subjects: 20
Study 31830082 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait (Amputee Intact vs. Residual Knee)
Number of subjects: 20
Study 31830082 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait (Amputee Residual vs. Intact Knee)
Number of subjects: 20
Study 31830082 — intervention group
Group type: EXPERIMENTAL
Intervention: Elliptical (Amputee Residual vs. Intact Knee)
Number of subjects: 20
Study 31830082 — intervention group
Group type: COMPARATOR
Intervention: Gait (Amputee vs. Control)
Number of subjects: 20
Study 31830082 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait (Amputee)
Number of subjects: 20
Study 29433385 — intervention group
Group type: EXPERIMENTAL
Intervention: IV lidocaine infusion (bolus 1.5 mg/kg followed by a continuous infusion at the rate of 2 mg/kg/hr until skin closure)
Number of subjects: 60
Study 29433385 — intervention group
Group type: EXPERIMENTAL
Intervention: IV lidocaine infusion
Number of subjects: 60
Study 29433385 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (0.9% NaCl solution)
Number of subjects: 60
Study 26306716 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation treatment (MRT)
Number of subjects: 122
Study 26306716 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 122
Study 25305156 — intervention group
Group type: EXPERIMENTAL
Intervention: PiB+ (β‐amyloid deposition)
Number of subjects: 183
Study 25305156 — intervention group
Group type: EXPERIMENTAL
Intervention: Small hippocampal volume
Number of subjects: 183
Study 25305156 — intervention group
Group type: EXPERIMENTAL
Intervention: WML volume
Number of subjects: 183
Study 25305156 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of imaging abnormalities (PiB+, small hippocampi, WMLs)
Number of subjects: 183
Study 25305156 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous variables of PiB retention, left and right hippocampal volume, and WML volume
Number of subjects: 183
Study 22228285 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual patient trainer
Number of subjects: 93
Study 22228285 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture
Number of subjects: 93
Study 20164311 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern intervention
Number of subjects: 2730
Study 20164311 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern intervention in diabetic white women
Number of subjects: 2730
Study 20164311 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern intervention in diabetic black women
Number of subjects: 2730
Study 16550311 — intervention group
Group type: COMPARATOR
Intervention: Standard dose bolus of tirofiban (10 microg/kg/3 min) with 24‐h infusion at a rate of 0.15 microg/kg/min
Number of subjects: 100
Study 16550311 — intervention group
Group type: EXPERIMENTAL
Intervention: Single high-dose bolus tirofiban (25 microg/kg/3 min)
Number of subjects: 100
Study 15157751 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental stress (laboratory speech stressor task)
Number of subjects: 48
Study 15157751 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood assessment (Hamilton Rating Scales for Depression and Anxiety)
Number of subjects: 48
Study 10932083 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-blind placebo-controlled food challenge (DBPCFC) with celery
Number of subjects: 32
Study 10932083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 10932083 — intervention group
Group type: EXPERIMENTAL
Intervention: Open provocation with celery
Number of subjects: 32
Study 10932083 — intervention group
Group type: EXPERIMENTAL
Intervention: CAP method for specific IgE determination
Number of subjects: 32
Study 10932083 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin prick tests (SPTs) with commercial extracts
Number of subjects: 32
Study 10932083 — intervention group
Group type: EXPERIMENTAL
Intervention: Prick-to-prick tests with crude celery
Number of subjects: 32
Study 10932083 — intervention group
Group type: EXPERIMENTAL
Intervention: SPT and CAP tests
Number of subjects: 32
Study 9305603 — intervention group
Group type: EXPERIMENTAL
Intervention: St Jude-type multiagent chemotherapy
Number of subjects: 23
Study 9305603 — intervention group
Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 23
Study 9305603 — intervention group
Group type: EXPERIMENTAL
Intervention: St Jude-type multiagent chemotherapy (for good-prognosis subgroup)
Number of subjects: 23
Study 8361895 — intervention group
Group type: EXPERIMENTAL
Intervention: Molsidomine (2 mg, single oral dose)
Number of subjects: 33
Study 8361895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 2423807 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoramin alone (n = 58)
Number of subjects: 215
Study 2423807 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoramin plus thiazide diuretic (n = 157)
Number of subjects: 215
Study 31975638 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic band group (Theraband®)
Number of subjects: 48
Study 31975638 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic tubes training using Lemgruber® (ETG)
Number of subjects: 48
Study 31975638 — intervention group
Group type: COMPARATOR
Intervention: Conventional training with weight machine equipment (CG)
Number of subjects: 48
Study 31999484 — intervention group
Group type: EXPERIMENTAL
Intervention: Pickup trucks transporting people in the cargo area
Number of subjects: 4611
Study 31999484 — intervention group
Group type: EXPERIMENTAL
Intervention: León
Number of subjects: 4611
Study 31999484 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuernavaca
Number of subjects: 4611
Study 31999484 — intervention group
Group type: EXPERIMENTAL
Intervention: Guadalajara‐Zapopan
Number of subjects: 4611
Study 31999484 — intervention group
Group type: EXPERIMENTAL
Intervention: Male drivers not using seatbelt correctly
Number of subjects: 4611
Study 30621749 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 94
Study 30621749 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil (REMI)
Number of subjects: 94
Study 28592188 — intervention group
Group type: EXPERIMENTAL
Intervention: SEC-coated CPB circuit
Number of subjects: 12
Study 28592188 — intervention group
Group type: COMPARATOR
Intervention: Non-coated CPB circuit
Number of subjects: 12
Study 26072289 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 months androgen suppression (AS)
Number of subjects: 0
Study 26072289 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation dose escalation (RDE)
Number of subjects: 0
Study 26072289 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose rate brachytherapy boost (HDRB)
Number of subjects: 0
Study 26072289 — intervention group
Group type: COMPARATOR
Intervention: Control group (6 months AS)
Number of subjects: 0
Study 26072289 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-radiation urethral strictures
Number of subjects: 0
Study 23419410 — intervention group
Group type: EXPERIMENTAL
Intervention: High perfectionistic rearing behaviors
Number of subjects: 77
Study 23419410 — intervention group
Group type: COMPARATOR
Intervention: Non-perfectionistic rearing behaviors
Number of subjects: 77
Study 21643673 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 72
Study 21643673 — intervention group
Group type: EXPERIMENTAL
Intervention: Reserpine
Number of subjects: 72
Study 21643673 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 72
Study 21643673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 18789492 — intervention group
Group type: EXPERIMENTAL
Intervention: JTT‐705 600 mg/d
Number of subjects: 18
Study 18789492 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 17365206 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (pharmacists trained in asthma education)
Number of subjects: 48
Study 17365206 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (pharmacist researcher trained as asthma educator)
Number of subjects: 48
Study 17365206 — intervention group
Group type: COMPARATOR
Intervention: Group C (usual care by community pharmacists)
Number of subjects: 48
Study 17365206 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (MDI technique)
Number of subjects: 48
Study 17365206 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (MDI technique)
Number of subjects: 48
Study 17365206 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (DPI technique)
Number of subjects: 48
Study 17365206 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (DPI technique)
Number of subjects: 48
Study 17365206 — intervention group
Group type: COMPARATOR
Intervention: Group C (inhaler technique)
Number of subjects: 48
Study 17365206 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A and B (asthma knowledge scores)
Number of subjects: 48
Study 16305570 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered isoflurane and desflurane
Number of subjects: 396
Study 16305570 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 396
Study 12028976 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapist delivered intervention (training in pelvic floor exercises and strategies to improve adherence)
Number of subjects: 676
Study 12028976 — intervention group
Group type: COMPARATOR
Intervention: Usual postpartum care
Number of subjects: 676
Study 12028976 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapist delivered intervention
Number of subjects: 676
Study 9708557 — intervention group
Group type: EXPERIMENTAL
Intervention: Uptake of oxidized vitamin C (dehydroascorbic acid) via GLUT1 into erythrocytes
Number of subjects: 2
Study 7607764 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis (pre-hospital)
Number of subjects: 1516
Study 7607764 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis (hospital)
Number of subjects: 1516
Study 7607764 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis (total)
Number of subjects: 1516
Study 7607764 — intervention group
Group type: EXPERIMENTAL
Intervention: Resuscitation
Number of subjects: 1516
Study 7607764 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis (GREAT trial)
Number of subjects: 1516
Study 7607764 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis (overall)
Number of subjects: 1516
Study 7607764 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac arrest (hospital patients)
Number of subjects: 1516
Study 2225366 — intervention group
Group type: EXPERIMENTAL
Intervention: Special Intervention (SI) program
Number of subjects: 8012